Dr. Lu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1601 Liberty St
Richmond, TX 77469Phone+1 281-342-6962Fax+1 281-342-6963
Education & Training
- Beijing Medical UniversityClass of 1992
Certifications & Licensure
- TX State Medical License 2019 - 2025
- NY State Medical License 2019 - 2021
- LA State Medical License 2019 - 2019
Publications & Presentations
PubMed
- 35 citationsTargeting Src and tubulin in mucinous ovarian carcinomaTao Liu, Wei Hu, Heather J. Dalton, Hyun Jin Choi, Jie Huang
Clinical Cancer Research. 2013-12-01 - 49 citationsClinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancerWilliam M. Merritt, Aparna A. Kamat, Jee Young Hwang, Justin Bottsford-Miller, Chunhua Lu
Cancer Biology & Therapy. 2010-12-15 - 106 citationsEfficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer.Charles N. Landen, Chunhua Lu, Liz Y. Han, Karen Coffman, Elizabeth Bruckheimer
Journal of the National Cancer Institute. 2006-11-01
Press Mentions
- InnoCare Announces the Approval of Orelabrutinib in China for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma and Relapsed/Refractory Mantle Cell LymphomaDecember 27th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: